Abstract 471: Impact of Enrichment Strategies for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy in Primary Prevention Settings
Publication Date
2015
Presented At:
American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease (THR Peripheral 2015 Sessions)
Content Type
Presentation
Publisher's Site:
Citation
Arteriosclerosis, Thrombosis, and Vascular Biology 35(Suppl 1):A471